Bioventus
BVS
BVS
105 hedge funds and large institutions have $447M invested in Bioventus in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 41 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $451M → $447M (-$4.43M)
22% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 41
97% less call options, than puts
Call options by funds: $2K | Put options by funds: $69K
Holders
105
Holding in Top 10
4
Calls
$2K
Puts
$69K
Top Buyers
| 1 | +$12.7M | |
| 2 | +$9.97M | |
| 3 | +$2.19M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$1.39M |
| 5 |
First Eagle Investment Management
New York
|
+$1.36M |
Top Sellers
| 1 | -$6.21M | |
| 2 | -$6.14M | |
| 3 | -$3.58M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.32M |
| 5 |
MIM
Meros Investment Management
Dallas,
Texas
|
-$1.65M |